BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hanssen NMJ, de Vos WM, Nieuwdorp M. Fecal microbiota transplantation in human metabolic diseases: From a murky past to a bright future? Cell Metab 2021;33:1098-110. [PMID: 34077717 DOI: 10.1016/j.cmet.2021.05.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Qu Z, Tian P, Yang B, Zhao J, Wang G, Chen W. Fecal microbiota transplantation for diseases: Therapeutic potential, methodology, risk management in clinical practice. Life Sci 2022;304:120719. [PMID: 35716734 DOI: 10.1016/j.lfs.2022.120719] [Reference Citation Analysis]
2 Zhu LY, Huang BW, Zhang XL, Zhu N. Progress in application of probiotics, prebiotics, and synbiotics in irritable bowel syndrome. Shijie Huaren Xiaohua Zazhi 2022; 30(8): 375-380 [DOI: 10.11569/wcjd.v30.i8.375] [Reference Citation Analysis]
3 Callender C, Attaye I, Nieuwdorp M. The Interaction between the Gut Microbiome and Bile Acids in Cardiometabolic Diseases. Metabolites 2022;12:65. [PMID: 35050187 DOI: 10.3390/metabo12010065] [Reference Citation Analysis]
4 Gopalkrishna S, Johnson J, Jaggers RM, Dahdah A, Murphy AJ, Hanssen NMJ, Nagareddy PR. Neutrophils in cardiovascular disease: Warmongers, peacemakers or both? Cardiovasc Res 2021:cvab302. [PMID: 34534269 DOI: 10.1093/cvr/cvab302] [Reference Citation Analysis]
5 Junca H, Pieper DH, Medina E. The emerging potential of microbiome transplantation on human health interventions. Computational and Structural Biotechnology Journal 2022. [DOI: 10.1016/j.csbj.2022.01.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Hanssen NMJ, Nieuwdorp M. Fecal microbiota transplantation and fiber supplementation, better together? Cell Rep Med 2021;2:100403. [PMID: 34622239 DOI: 10.1016/j.xcrm.2021.100403] [Reference Citation Analysis]
7 Yan Y, Wang J, Qiu S, Duan Y, Si W, Claesen J. The Lumenal Microbiota Varies Biogeographically in the Gastrointestinal Tract of Rhesus Macaques. Microbiol Spectr. [DOI: 10.1128/spectrum.00343-22] [Reference Citation Analysis]
8 Turjeman S, Koren O. Using the microbiome in clinical practice. Microb Biotechnol 2022;15:129-34. [PMID: 34767683 DOI: 10.1111/1751-7915.13971] [Reference Citation Analysis]
9 Pinxt CMH, Bogie RMM, Hanssen NMJ, Spaetgens B. Antibiotic overuse in older patients: An important clinical reminder of pseudomembranous colitis. QJM 2021:hcab198. [PMID: 34270783 DOI: 10.1093/qjmed/hcab198] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Teunis C, Nieuwdorp M, Hanssen N. Interactions between Tryptophan Metabolism, the Gut Microbiome and the Immune System as Potential Drivers of Non-Alcoholic Fatty Liver Disease (NAFLD) and Metabolic Diseases. Metabolites 2022;12:514. [DOI: 10.3390/metabo12060514] [Reference Citation Analysis]
11 Wortelboer K, Bakker GJ, Winkelmeijer M, van Riel N, Levin E, Nieuwdorp M, Herrema H, Davids M. Fecal microbiota transplantation as tool to study the interrelation between microbiota composition and miRNA expression. Microbiological Research 2022. [DOI: 10.1016/j.micres.2022.126972] [Reference Citation Analysis]
12 Daniel H. Diet and Gut Microbiome and the “Chicken or Egg” Problem. Front Nutr 2022;8:828630. [DOI: 10.3389/fnut.2021.828630] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Bian J, Liebert A, Bicknell B, Chen XM, Huang C, Pollock CA. Faecal Microbiota Transplantation and Chronic Kidney Disease. Nutrients 2022;14:2528. [PMID: 35745257 DOI: 10.3390/nu14122528] [Reference Citation Analysis]
14 Wortelboer K, Herrema H. Shedding light on dark matter - faecal microbiota transplantation in Europe. Lancet Reg Health Eur 2021;9:100187. [PMID: 34693389 DOI: 10.1016/j.lanepe.2021.100187] [Reference Citation Analysis]
15 Zhou A, Yuan Y, Yang M, Huang Y, Li X, Li S, Yang S, Tang B. Crosstalk Between the Gut Microbiota and Epithelial Cells Under Physiological and Infectious Conditions. Front Cell Infect Microbiol 2022;12:832672. [DOI: 10.3389/fcimb.2022.832672] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
16 de Vos WM, Tilg H, Van Hul M, Cani PD. Gut microbiome and health: mechanistic insights. Gut 2022;71:1020-32. [PMID: 35105664 DOI: 10.1136/gutjnl-2021-326789] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 19.0] [Reference Citation Analysis]
17 Thirion F, Da Silva K, Plaza Oñate F, Alvarez AS, Thabuis C, Pons N, Berland M, Le Chatelier E, Galleron N, Levenez F, Vergara C, Chevallier H, Guérin-Deremaux L, Doré J, Ehrlich SD. Diet Supplementation with NUTRIOSE, a Resistant Dextrin, Increases the Abundance of Parabacteroides distasonis in the Human Gut. Mol Nutr Food Res 2022;66:e2101091. [PMID: 35312171 DOI: 10.1002/mnfr.202101091] [Reference Citation Analysis]